Charlotte Casebourne

Charlotte believes in equitable access to effective therapies. In addition to her role with Theolytics, she is a Board Member of the UK BioIndustry Association. She has also been recently named one of In Vivo‘s 20 Rising Leaders in Life Sciences.

Previously with New Medicine Partners, Charlotte is an entrepreneur with international leadership, operational and management experience. She has worked with government ministries, national funding bodies and research institutes to transform life science technologies into commercially viable products. She previously held leadership roles with the WEF Global Shapers Network; HealthTech Women; and Hello Tomorrow.

Charlotte graduated as a University of Cambridge Bioscience Enterprise M.Phil Scholar and was a shortlisted finalist for Cambridge Entrepreneur of the Year.